ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,024.65
0.85%
Dow Jones
43,169.49
-0.29%
US Dollar vs MXN
20.14079
-0.12%
Brent Oil
73.665
0.52%
Bitcoin
95,546.34
-3.78%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Eupraxia Pharmaceuticals Inc (EPRX) Cotización

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
2.75
-0.36
( -11.58% )
Actualizado: 08:30:01
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
2.75
Postura de Compra
2.75
Postura de Venta
3.04
Volume Operado de la Acción
64
2.75 Rango del Día 2.75
2.20 Rango de 52 semanas 4.08
Capitalización de Mercado [m]
97.962M
Precio Anterior
3.11
Precio de Apertura
2.75
Hora
54
@
2.75
Última hora de negociación
08:30:01
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
18,261
Acciones en circulación
35,622,553
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.67
Beneficio por acción (BPA)
-0.79
turnover
-
Beneficio neto
-28.22M

Acerca de Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.eupraxiapharma.com
Sede
Victoria, British Columbia, Can
Fundado
-
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was US$3.11. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of US$ 2.20 to US$ 4.08.

Eupraxia Pharmaceuticals currently has 35,622,553 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is US$110.79 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.67.

EPRX Últimas noticias

Más noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 Noviembre 2024
Edgar (US Regulatory)

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...

20 Noviembre 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 Noviembre 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...

14 Noviembre 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 Noviembre 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

13 Noviembre 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis PR Newswire VICTORIA, BC, Nov. 12, 2024 One...

12 Noviembre 2024
PR Newswire (US)

Form D - Notice of Exempt Offering of Securities

08 Noviembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

07 Noviembre 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...

07 Noviembre 2024
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.37-11.8589743593.123.17882.7560063.02522021CS
4-0.85-23.61111111113.63.632.75109413.26367215CS
120.00750.2734731084782.74254.082.2182613.1902336CS
260.145.363984674332.614.082.2122743.02457409CS
52-0.8-22.53521126763.554.082.2163122.94415018CS
156-0.8-22.53521126763.554.082.2163122.94415018CS
260-0.8-22.53521126763.554.082.2163122.94415018CS

EPRX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Eupraxia Pharmaceuticals?
El precio actual de las acciones de Eupraxia Pharmaceuticals es US$ 2.75
¿Cuántas acciones de Eupraxia Pharmaceuticals están en circulación?
Eupraxia Pharmaceuticals tiene 35,622,553 acciones en circulación
¿Cuál es la capitalización de mercado de Eupraxia Pharmaceuticals?
La capitalización de mercado de Eupraxia Pharmaceuticals es USD 110.79M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals ha negociado en un rango de US$ 2.20 a US$ 4.08 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Eupraxia Pharmaceuticals?
El ratio precio/beneficio de Eupraxia Pharmaceuticals es -5.67
¿Cuál es la moneda de reporte de Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Eupraxia Pharmaceuticals?
El último beneficio anual de Eupraxia Pharmaceuticals es USD -28.22M
¿Cuál es la dirección registrada de Eupraxia Pharmaceuticals?
La dirección registrada de Eupraxia Pharmaceuticals es 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.
¿Cuál es la dirección del sitio web de Eupraxia Pharmaceuticals?
La dirección del sitio web de Eupraxia Pharmaceuticals es www.eupraxiapharma.com
¿En qué sector industrial opera Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AALAmerican Airlines Group Inc
US$ 17.35
(0.00%)
73.07k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70.2201
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.00
(0.00%)
7.05k
AACGATA Creativity Global
US$ 0.79
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.35
(0.00%)
73.07k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70.2201
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.00
(0.00%)
7.05k
AACGATA Creativity Global
US$ 0.79
(0.00%)
0
SPRCSciSparc Ltd
US$ 0.2212
(0.00%)
112.93M
COEPCoeptis Therapeutics Holdings Inc
US$ 0.142
(0.00%)
61.98M
SMXSMX Security Matters Public Company
US$ 0.218
(0.00%)
58.76M
LICNLichen China Limited
US$ 0.2101
(0.00%)
28.2M
MGIHMillennium Group International Holdings Ltd
US$ 1.53
(0.00%)
27.61M

Discusión

Ver feed completo
CMDawg CMDawg 2 minutos hace
What is trade,/code 453 shares 
ELTP
crazy horse 0 crazy horse 0 2 minutos hace
That would be something if TRUMP does this Larry

The Nicaragua Alternative

Nicaraguan President Daniel Ortega is a political pariah in many respects, and the latest round of constitutional amendments that bolster his power are being met internationally with a level of c
researcher59 researcher59 2 minutos hace
PSIX (34.15) showing volume of 72k on ToS
Runners123 Runners123 2 minutos hace
SOBR $1.15 is the float really under 1 mil? or is that an error?
SOBR
crowin crowin 2 minutos hace
Everyone is RDAR HAPPY
RDAR
abew4me abew4me 3 minutos hace
Anyone know why WATT is up and trading over 12 million shares this morning?
WATT
luvwetscent luvwetscent 3 minutos hace
Sorry, but baloney
ELTP
StayHumble StayHumble 3 minutos hace
Yes💹$DJT launching $100+💹PE Ratio is +475 Facts Matter🇺🇸Maybe
DJT
DiscoverGold DiscoverGold 3 minutos hace
The 10 Top/Bottom S&P 500 Index percent net change performers
By: Thom Hartle | December 26, 2024

• Today (8:40 CST), the 10 top/bottom percent net change performers in the S&P 500 Index.

pbs.twimg.com/media/Gfu3QENXwAApmDk?format=jpg&name=900x900
bucks2pennies bucks2pennies 3 minutos hace
Huge write-off sales demand for tax purposes prior to 2025. Is there enough buyer frenzy to suck it up?
GTCH
Curt D Curt D 4 minutos hace
I agree. People are loading as much as they can before it runs. And some fence sitters are probably jumping in too.
RDAR
dukeb dukeb 4 minutos hace
I'm an abstainer. You're not trying to break me, are you?
PROPHET-of-PROFITS PROPHET-of-PROFITS 4 minutos hace
HERE WE GO...
RDAR
TheDane TheDane 4 minutos hace
Moving up! Slow but sure.
SMCI
Gus1212 Gus1212 4 minutos hace
We have news
NWBO
ReviveThomas ReviveThomas 4 minutos hace
what's going on this morning?
GEVO
Trooperstocks Trooperstocks 4 minutos hace
$ZENA Check out the IQ Nano in this San Francisco Chronicle article! This self-flying drone scans barcodes, cuts inventory costs, streamlines processes, and enables smarter inventory management.

Read the full article here: https://bit.ly/41OkyCg
ZENA
Trooperstocks Trooperstocks 4 minutos hace
$ZENA Check out the IQ Nano in this San Francisco Chronicle article! This self-flying drone scans barcodes, cuts inventory costs, streamlines processes, and enables smarter inventory management.

Read the full article here: https://bit.ly/41OkyCg
ZENA
firebag1 firebag1 4 minutos hace
RDAR!!! Nice!!!
RDAR
abew4me abew4me 4 minutos hace
Anyone know why WATT is up and trading over 12 Million shares?!!!
WATT
DiscoverGold DiscoverGold 4 minutos hace
The 10 Top/Bottom Nasdaq 100 Index percent net change performers
By: Thom Hartle | December 26, 2024

• Today (8:40 CST), the 10 top/bottom percent net change performers in the NASDAQ 100 Index.

pbs.twimg.com/media/Gfu3KldXkAAmJGy?format=jpg&name=900x900
RIGATONI RIGATONI 4 minutos hace
Looks great, the numbers again for those who missed this...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175578092
learningcurve2020 learningcurve2020 4 minutos hace
Guru Gary actually dominated the board yesterday with his random thoughts.  
NWBO
BuddyGuise BuddyGuise 4 minutos hace
$ELTP Love the news! Unfortunate to put it out when most won't be paying attention during the holiday break except for those ELTP junkies like us! Not expecting huge volume till after the New Year, but am willing to be surprised. Good time to add shares before they go parabolic.
ELTP
devil dog 96 devil dog 96 5 minutos hace
Your trading advice is reckless and you want traders to thank you for it. 😃 LMAO

" Sell the open and thank me later "

https://investorshub.advfn.com/uimage/uploads/2024/12/26/o[lrgScreenshot_2024-12-26_093718.jpg


$RUM & $RUMBW
RUM

Su Consulta Reciente

NASDAQ
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados